BR112019018090A2 - Sondas de cálcio fluorescentes para avaliar a eficácia da composição para tratamento bucal em biofilme - Google Patents

Sondas de cálcio fluorescentes para avaliar a eficácia da composição para tratamento bucal em biofilme Download PDF

Info

Publication number
BR112019018090A2
BR112019018090A2 BR112019018090-7A BR112019018090A BR112019018090A2 BR 112019018090 A2 BR112019018090 A2 BR 112019018090A2 BR 112019018090 A BR112019018090 A BR 112019018090A BR 112019018090 A2 BR112019018090 A2 BR 112019018090A2
Authority
BR
Brazil
Prior art keywords
biofilm
composition
efficacy
evaluate
oral treatment
Prior art date
Application number
BR112019018090-7A
Other languages
English (en)
Inventor
Shi Yunming
Basa Swapna
Strand Ross
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of BR112019018090A2 publication Critical patent/BR112019018090A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

a presente invenção se refere a um método de quantificação de cálcio em um biofilme que é uma forma eficaz de avaliar a eficácia de uma composição para tratamento bucal para ajudar a inibir a formação do biofilme ou ajudar a romper o biofilme.
BR112019018090-7A 2017-03-03 2017-03-03 Sondas de cálcio fluorescentes para avaliar a eficácia da composição para tratamento bucal em biofilme BR112019018090A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/075538 WO2018157368A1 (en) 2017-03-03 2017-03-03 Calcium fluorescent probes to assess oral care composition efficacy in biofilm

Publications (1)

Publication Number Publication Date
BR112019018090A2 true BR112019018090A2 (pt) 2020-03-24

Family

ID=63369676

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019018090-7A BR112019018090A2 (pt) 2017-03-03 2017-03-03 Sondas de cálcio fluorescentes para avaliar a eficácia da composição para tratamento bucal em biofilme

Country Status (7)

Country Link
US (1) US20190352719A1 (pt)
EP (1) EP3589949A1 (pt)
CN (1) CN110382706A (pt)
BR (1) BR112019018090A2 (pt)
CA (1) CA3053680A1 (pt)
MX (1) MX2019010358A (pt)
WO (1) WO2018157368A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021007529A (es) * 2018-12-26 2021-08-05 Colgate Palmolive Co Metodo de visualizacion para analizar el crecimiento de la biopelicula bucal.
CN112168123B (zh) * 2020-10-15 2023-01-20 山东艾博康生物科技有限公司 一种数据采集及传输的口腔检测仪
CA3220437A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309835B1 (en) 1999-05-27 2001-10-30 Koninkiijke Philips Electronics N.V. Methods for quantitating the efficacy of oral care products
CN102037360B (zh) * 2008-02-08 2016-10-05 高露洁-棕榄公司 口腔护理方法和系统
GB201020236D0 (en) * 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
BR112013020241A2 (pt) * 2011-02-11 2017-03-01 Colgate Palmolive Co métodos de análise de placa
US10143640B2 (en) * 2013-09-13 2018-12-04 Floss My Heart, Llc Fluorescence plaque-disclosant for detecting dental plaque
US10280444B2 (en) * 2016-09-09 2019-05-07 The Procter & Gamble Company Method of quantitating sorption of stannous by microbial cells of a biofilm

Also Published As

Publication number Publication date
CA3053680A1 (en) 2018-09-07
US20190352719A1 (en) 2019-11-21
MX2019010358A (es) 2019-10-22
WO2018157368A1 (en) 2018-09-07
EP3589949A1 (en) 2020-01-08
CN110382706A (zh) 2019-10-25

Similar Documents

Publication Publication Date Title
BR112019011689A2 (pt) tratamento de uma doença do trato gastrointestinal com um inibidor de tnf
BR112017007072A2 (pt) compostos de triazolopiridina e métodos para o tratamento de fibrose cística
BR112018004620A2 (pt) moduladores da expressão de kras
BR112014009993A2 (pt) método para o tratamento de tumores do estroma gastrointestinal
EA201370208A1 (ru) Формы рифаксимина и их применение
CY1115736T1 (el) Νεες συνθεσεις για αντιμετωπιση cmt και σχετικων διαταραχων
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
NI201600021A (es) Inhibidores de rorc2 heterobicicloarilo y sus métodos de uso
UY37017A (es) Inhibidores aza-bencimidazol de pad4
BR112015023026A2 (pt) indicador de esterilização para esterilizantes oxidativos e processo para determinar a eficácia de um processo de esterilização utilizando esterilizantes oxidativos
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
CL2015003049A1 (es) Variantes de pertuzumab y su evaluación
TR201905233T4 (tr) Dirençli bakteriyel enfeksiyonların tedavisine yönelik kombinasyon tedavisi.
SV2010003648A (es) Inhibidores del receptor de quimioquinas cxcr3
BR112019018090A2 (pt) Sondas de cálcio fluorescentes para avaliar a eficácia da composição para tratamento bucal em biofilme
CY1120877T1 (el) Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης
BR112018069147A2 (pt) composto da fórmula iii, composição farmacêutica, método de inibição da função de fimh e método de tratamento de uma doença mediada por fimh
DOP2016000120A (es) Nuevos inhibidores de dgat2
BR112015018360A2 (pt) terapia de combinação para o tratamento de pneumonia nosocomial
BR112017023750A2 (pt) desintoxicação de fatores de virulência microbiana na cavidade bucal
BR112017028543A2 (pt) método para tratar pastas fluidas minerais com um biocida
EA201792641A1 (ru) Ингибитор оси igfbp3/tmem219 и диабет
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
CY1120666T1 (el) Μεθοδος για τη θεραπεια ελλειμματων οστικου κενου
BR112018001451A2 (pt) compostos úteis para a inibição de ror-gama-t

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2712 DE 27-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.